29 related articles for article (PubMed ID: 38522311)
1. Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma.
Yang X; Li S; Xu C; Liu S; Zhang X; Lian B; Li M
Cancer Biol Ther; 2024 Dec; 25(1):2365449. PubMed ID: 38865161
[TBL] [Abstract][Full Text] [Related]
2. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.
Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X
Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatocellular carcinoma cell proliferation through regulation of the Cell Cycle, AGE-RAGE, and Leptin signaling pathways by a compound formulation comprised of andrographolide, wogonin, and oroxylin A derived from Andrographis Paniculata(Burm.f.) Nees.
Gao S; Tan H; Gang J
J Ethnopharmacol; 2024 Jul; 329():118001. PubMed ID: 38467318
[TBL] [Abstract][Full Text] [Related]
4. LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN.
Li W; Huang K; Wen F; Cui G; Guo H; He Z; Zhao S
EBioMedicine; 2019 Jun; 44():298-310. PubMed ID: 31201145
[TBL] [Abstract][Full Text] [Related]
5. Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis.
Zhang Y; Wei S; Zhang Q; Zhang Y; Sun C
Phytomedicine; 2024 Jul; 130():155746. PubMed ID: 38763012
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of Ω-3 polyunsaturated fatty acid supplementation and programmed cell death protein 1 blockade on tumor growth and immune modulation in a xenograft model of esophageal cancer.
Xiao X; Luo S; Huang J; Wan B; Bi N; Wang J
Clin Nutr ESPEN; 2024 Jun; 61():308-315. PubMed ID: 38777449
[TBL] [Abstract][Full Text] [Related]
7. Polyphyllin VII Promotes Apoptosis in Breast Cancer by Inhibiting MAPK/ERK Signaling Pathway through Downregulation of SOS1.
Du SG; Zhang HM; Ji YX; Tian YL; Wang D; Zhu K; Zhang QG; Liu SP
Am J Chin Med; 2024; 52(3):885-904. PubMed ID: 38716619
[TBL] [Abstract][Full Text] [Related]
8. OXPHOS-targeting drugs in oncology: new perspectives.
Kalyanaraman B; Cheng G; Hardy M; You M
Expert Opin Ther Targets; 2023; 27(10):939-952. PubMed ID: 37736880
[TBL] [Abstract][Full Text] [Related]
9. The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma.
Tao J; Zhao H; Xie X; Luo M; Gao Z; Sun H; Huang Z
Onco Targets Ther; 2019; 12():471-478. PubMed ID: 30666126
[TBL] [Abstract][Full Text] [Related]
10. Mito-Specific Nutri-Hijacker Synergizing Mitochondrial Metabolism and Glycolysis Intervention for Enhanced Antitumor Bioenergetic Therapy.
Yang J; Chu M; Zhang Y; Qian J; Liu J; Wang M; Qiang Z; Ren J
ACS Appl Mater Interfaces; 2024 Jun; 16(23):29902-29916. PubMed ID: 38809117
[TBL] [Abstract][Full Text] [Related]
11. Proline oxidase functions as a mitochondrial tumor suppressor in human cancers.
Liu Y; Borchert GL; Donald SP; Diwan BA; Anver M; Phang JM
Cancer Res; 2009 Aug; 69(16):6414-22. PubMed ID: 19654292
[TBL] [Abstract][Full Text] [Related]
12. Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells.
Hu WB; Liu YT; Li J; Wang Y; Sun XZ; Hua MY; Liu XT; Hui BN
Toxicol In Vitro; 2024 Jun; 99():105867. PubMed ID: 38848824
[TBL] [Abstract][Full Text] [Related]
13. Retraction notice to "LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN" [EBioMedicine 44 (2019) 298-310].
Li W; Huang K; Wen F; Cui G; Guo H; He Z; Zhao S
EBioMedicine; 2024 Jun; 104():105192. PubMed ID: 38833840
[No Abstract] [Full Text] [Related]
14. Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy.
Han L; Xiang X; Fu Y; Wei S; Zhang C; Li L; Liu Y; Lv H; Shan B; Zhao L
Phytomedicine; 2024 Jun; 128():155539. PubMed ID: 38522311
[TBL] [Abstract][Full Text] [Related]
15. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy.
Han L; Dai S; Li Z; Zhang C; Wei S; Zhao R; Zhang H; Zhao L; Shan B
J Exp Clin Cancer Res; 2019 Dec; 38(1):501. PubMed ID: 31864387
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
[TBL] [Abstract][Full Text] [Related]
17. Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma.
Wang J; Zhang Z; Che Y; Yuan Z; Lu Z; Li Y; Wan J; Sun H; Chen Z; Pu J; He J
Cancer Chemother Pharmacol; 2018 Mar; 81(3):469-481. PubMed ID: 29308536
[TBL] [Abstract][Full Text] [Related]
18. α-Hederin Induces Apoptosis of Esophageal Squamous Cell Carcinoma via an Oxidative and Mitochondrial-Dependent Pathway.
Wang J; Wu D; Zhang J; Liu H; Wu J; Dong W
Dig Dis Sci; 2019 Dec; 64(12):3528-3538. PubMed ID: 31273592
[TBL] [Abstract][Full Text] [Related]
19. Advancing oral health: Harnessing the potential of chitosan and polyphenols in innovative mouthwash formulation.
Maj M; Tylkowski B; Konopka P; Woźniak-Budych M; Staszak K; Staszak M; Kaźmierski Ł; Bajek A; Jastrzab R
Biomed Pharmacother; 2024 Jun; 175():116654. PubMed ID: 38692066
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
